Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
BQ.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-3339.71China
BQ.1.1.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.66NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.66NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used